Monday, September 21, 2026
6:00 PM – 6:30 PM Registration & Dinner
6:30 PM – 7:30 PM Educational Program
Venue TBD
Miami, FL
PROGRAM FEATURES
- 1.0 CME/CNE CREDITS
- Complimentary Dinner
- Interactive, case-based learning environment
- Downloadable animations, resources, and tools
- Create your own personalized poster
PRESENTING FACULTY
 |
Luis Haddock, MD Associate Professor of Ophthalmology Bascom Palmer Eye Institute-University of Miami Miami, Florida |
PROGRAM OVERVIEW
This live Grand Rounds will address key clinical challenges in nAMD management, focusing on how next-generation anti-VEGF therapies may reduce patient burden and support evolving treatment goals. The program will review pivotal trials and real-world data on durability, interval extension, and safety. Learners will participate in interactive, case-based discussions, with practical guidance on selecting, sequencing, and extending therapy. Faculty will share clinical pearls, and a patient perspective segment will help reinforce real-world application.
TARGET AUDIENCE
This initiative is designed to meet the educational needs of retina specialists and comprehensive ophthalmologists involved in the management of patients with retinal disease.
LEARNING OBJECTIVES
Upon the completion of this program, attendees should be able to:
- Apply evidence‑based criteria to select and sequence next‑generation anti-VEGF agents in both treatment‑naïve and treatment‑experienced nAMD patients
- Implement strategies to safely extend treatment intervals with next-generation anti-VEGF agents in nAMD patients to optimize durability and reduce patient burden
JOINT ACCREDITATION STATEMENT
In support of improving patient care, Med Learning Group is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
PHYSICIAN CREDIT DESIGNATION STATEMENT
Med Learning Group designates this live activity for a maximum of 1.0 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the live activity.
NURSES (ANCC) CREDIT DESIGNATION
Med Learning Group designates this activity for a maximum of 1.0 ANCC contact hour.
AAPA CREDIT DESIGNATION STATEMENT – Live
Med Learning Group has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credit.
ACCME INNOVATION PARTNER
Med Learning Group (MLG) is proud to be recognized as an ACCME Innovation Partner, leading the way in simplifying CME for physicians. As an Innovation Partner, MLG will be working with the ACCME by submitting credits directly to CME Passport.
PHYSICIAN DISCLAIMER: Upon your acceptance in the evaluation and completion of this CME activity, Med Learning Group will share your completion information and certain personal details (e.g., name, National Provider Identifier, birthdate MM/DD) with the ACCME for inclusion in your CME Passport transcript and, as applicable, reporting to certifying, licensing, or other regulatory authorities you specify.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
DISCLAIMER
Med Learning Group makes every effort to develop CE activities that are science based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.
For CE questions, please contact Med Learning Group at [email protected]
Contact this CE provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Event staff will be glad to assist you with any special needs (eg, physical, dietary, etc). Please contact Med Learning Group prior to participating at [email protected]
